SIACharts Logo

Amgen Inc (AMGN)

Biotech giant Amgen (AMGN) spent most of the first half of this year stuck in the red zone of the SIA S&P 100 Index Report. Since August, however, it has been steadily making its way back up the relative strength rankings. Yesterday, after jumping 11 positions to 25th place, capping off a gain of 26 places in the last month, Amgen returned to the Green Favored Zone for the first time since December of 2022.

iShares MSCI ACWI Ex US Index ETF (ACWX) & SPDR S&P Bank ETF (KBE)

In this edition of Equity Leaders Weekly, we look at recent trends in international equity markets and at the US banking sector heading into its earnings week.

Keep up to date on the latest financial market news.

Receive a daily newsletter with stock highlights, ETF rankings, weekly market focus and others.